Replimune Stock Forecast - Daily Balance Of Power

REPL Stock  USD 12.49  0.48  4.00%   
Replimune Stock Forecast is based on your current time horizon. Although Replimune's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Replimune's systematic risk associated with finding meaningful patterns of Replimune fundamentals over time.
  
The value of Payables Turnover is estimated to slide to 0.54. The value of Common Stock Shares Outstanding is expected to slide to about 47.1 M. Net Loss is expected to rise to about (100.9 M) this year.
On November 20, 2023 Replimune Group had Daily Balance Of Power of (0.05). Balance of Power indicator (or BOP) measures the strength of Replimune Group market sensitivity to bulls and bears. It estimates the ability of Replimune buyers and sellers to push price to an extreme high or extreme low level. As a result, by monitoring Replimune Balance of Power indicator one can determine a trend of the price direction.
Check Replimune VolatilityBacktest ReplimuneTrend Details  

Replimune Trading Date Momentum

On November 21 2023 Replimune Group was traded for  10.43  at the closing time. The top price for the day was 10.82  and the lowest listed price was  9.83 . The trading volume for the day was 882.3 K. The trading history from November 21, 2023 was a factor to the next trading day price upswing. The trading delta at closing time against the next closing price was 2.46% . The trading delta at closing time against the current closing price is 1.96% .
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare Replimune to competition

Other Forecasting Options for Replimune

For every potential investor in Replimune, whether a beginner or expert, Replimune's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Replimune Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Replimune. Basic forecasting techniques help filter out the noise by identifying Replimune's price trends.

View Replimune Related Equities

 Risk & Return  Correlation

Replimune Group Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Replimune's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Replimune's current price.

Replimune Market Strength Events

Market strength indicators help investors to evaluate how Replimune stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Replimune shares will generate the highest return on investment. By undertsting and applying Replimune stock market strength indicators, traders can identify Replimune Group entry and exit signals to maximize returns.

Replimune Risk Indicators

The analysis of Replimune's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Replimune's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting replimune stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Replimune Group is a strong investment it is important to analyze Replimune's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Replimune's future performance. For an informed investment choice regarding Replimune Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Replimune to cross-verify your projections.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Replimune. If investors know Replimune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Replimune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.04)
Return On Assets
(0.27)
Return On Equity
(0.50)
The market value of Replimune Group is measured differently than its book value, which is the value of Replimune that is recorded on the company's balance sheet. Investors also form their own opinion of Replimune's value that differs from its market value or its book value, called intrinsic value, which is Replimune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Replimune's market value can be influenced by many factors that don't directly affect Replimune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Replimune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Replimune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Replimune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.